ESTRADIOL VALERATE AND DIENOGEST

Pre-Launch

dienogest; estradiol valerate

Teva

ANDAORALTABLET

Lifecycle

Pre-Launch

Clinical Trials

Data completeness

3/8 — Basic

ESTRADIOL VALERATE AND DIENOGEST (dienogest; estradiol valerate) by Teva is ovulation. Approved for pregnancy.

Drug data last refreshed 1mo ago

Mechanism of Action

ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.

Indications (1)

pregnancy

Clinical Trials (1)

NCT01638910Phase 3Completed

Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

Started Jun 2012

955 enrolled

Contraception

Company

Worked on ESTRADIOL VALERATE AND DIENOGEST at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.